IRAK4 Kinase Assay Kit

Catalog #
78524
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The IRAK4 Kinase Assay Kit is designed to measure IRAK4 kinase activity for screening and profiling applications using ADP-Glo® as a detection reagent. 

Synonyms
Interleukin-1 receptor-associated kinase 4, IRAK-4, Renal carcinoma antigen NY-REN-64
Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Species
Human
Supplied As
The assay kit comes in a convenient 96-well format, with enough purified recombinant IRAK4 kinase, kinase substrate, ATP and kinase assay buffer for 100 enzyme reactions.
Materials Required But Not Supplied
  • ADP-Glo® Kinase Assay (Promega #6930)
  • Microplate reader capable of reading luminescence
  • Adjustable micropipettor and sterile tips
  • 30°C incubator
Format
Catalog # Name Amount Storage
40064 IRAK4, GST-tag Recombinant* 2.5 µg -80°C
79334 Kinase assay buffer 1 (5x) 1.5 ml -20°C
79686 ATP (500 µM) 100 µl -20°C
78514 Myelin basic protein (MBP), 5 mg/ml 100 µl -20°C
79696 White 96-well plate 1 Room Temp

*The concentration of the protein is lot-specific and will be indicated on the tube

UniProt #
Q9NWZ3
Background

IRAKs (interleukin receptor associated kinases) are a family of Serine/Threonine kinases that induce a protective acute inflammation response, as well as an adaptive immune response in the presence of pathogens. They are associated with Toll-like receptors in immune cells and transduce an intracellular signaling cascade that results in the transcription of genes involved in inflammation. Four IRAK-like molecules have been identified IRAK1, IRAK2, IRAK4 and IRAKM. IRAK1 and IRAK4 are active kinases, while IRAK2 and IRAKM are inactive.  All four kinases mediate activation of NFκB (nuclear factor kappa B), a regulator of innate immunity through signaling pathways that link pathogenic and cellular danger signals in response to invading pathogens. IRAKs have the potential to be used as therapeutic targets due to their highly functional role as mediators of immune response.

References

Janssens, S., et al,. Molecular Cell, (2003). 11(2), 293–302.